Results 21 to 30 of about 11,802 (200)

Carbapenem-resistant Acinetobacter baumannii and Carbapenem-resistant Enterobacterales in US Dialysis Populations, 2016-2021

Antimicrobial Stewardship & Healthcare Epidemiology
Background: Infections lead to high mortality among patients on chronic dialysis; knowledge of multi-drug resistant infections is limited. The Centers for Disease Control and Prevention’s Emerging Infections Program (EIP) conducts laboratory- and ...
Nadezhda Duffy, Christopher Czaja, Jesse Jacob, Shannon Novosad, Alice Guh, Danica Gomes, P. Maureen Cassidy, Sandra Bulens, Joshua Brandenburg, Gillian Smith, Elisabeth Vaeth, Joelle Nadle, Christopher Wilson, Julian Grass, Nicole Stabach, Kristina Flores, Helen Johnston, Ghinwa Dumyati, Sean O’Malley, Rebecca Pierce, Paula Snippes Vagnone, Ruth Lynfield, Daniel Muleta   +22 more
core   +3 more sources

Cefiderocol Susceptibility and Carbapenemase Profiles in Carbapenem-Resistant Enterobacterales. [PDF]

Infect Dis Clin Microbiol
Objective: Cefiderocol is a siderophore cephalosporin used as a last resort treatment for infections caused by carbapenem-resistant Enterobacterales (CRE), which pose a threat to public health. This study aimed to determine cefiderocol susceptibility among CRE isolates from the Western Marmara Region of Türkiye and to evaluate the association between ...
Bayrak A, Akçalı A, Mutlu R, Çakıcı N.   +3 more
europepmc   +4 more sources

Changes in Carbapenemase-Producing Carbapenem-Resistant Enterobacterales, 2019 to 2023. [PDF]

Ann Intern Med
Rankin DA, Stahl A, Sabour S, Khan MA, Armstrong T, Huang JY, Baggs J, Walters MS.   +7 more
europepmc   +4 more sources

Activity of mecillinam against carbapenem-resistant Enterobacterales

Journal of Antimicrobial Chemotherapy, 2022
Abstract Background Despite the fact that carbapenem-resistant Enterobacterales (CRE) mostly cause urinary tract infections (UTIs), only few studies have focused on the efficacity of mecillinam against these CRE.
Emeraud, Cécile, Godmer, Alexandre, Girlich, Delphine, Vanparis, Océane, Mahamdi, Fériel, Creton, Elodie, Jousset, Agnès, Naas, Thierry, Bonnin, Rémy, Dortet, Laurent   +9 more
openaire   +3 more sources

Comparing mortality in patients with carbapenemase-producing carbapenem resistant Enterobacterales and non-carbapenemase-producing carbapenem resistant Enterobacterales bacteremia

Diagnostic Microbiology and Infectious Disease, 2021
Carbapenem-resistant Enterobacterales (CRE) are classified as either carbapenemase-producing CRE (CP-CRE) or non-carbapenemase-producing CRE (non-CP-CRE) based on their mechanism of carbapenem resistance. Few studies have compared outcomes associated with each type of infection.
Michael R, Hovan, Navaneeth, Narayanan, Vanessa, Cedarbaum, Tanaya, Bhowmick, Thomas J, Kirn   +4 more
openaire   +5 more sources

Carbapenem-resistant Enterobacterales—Kentucky, 2013–2020

Journal of Appalachian health, 2023
Introduction: Carbapenem-resistant Enterobacterales (CRE) are considered urgent, antibiotic-resistant threats in the U.S. and are of global concern. Active collaboration between public health authorities and healthcare facilities and providers will be necessary to prevent and contain these organisms.
Issac, Mary, Flinchum, Andrea, Spicer, Kevin   +2 more
openaire   +2 more sources

A Review of Carbapenem Resistance in Enterobacterales and Its Detection Techniques

Microorganisms, 2023
Infectious disease outbreaks have caused thousands of deaths and hospitalizations, along with severe negative global economic impacts. Among these, infections caused by antimicrobial-resistant microorganisms are a major growing concern. The misuse and overuse of antimicrobials have resulted in the emergence of antimicrobial resistance (AMR) worldwide ...
Oznur Caliskan-Aydogan, Evangelyn C. Alocilja   +1 more
openaire   +3 more sources

Molecular epidemiology of carbapenem-resistant Enterobacterales in Thailand, 2016–2018 [PDF]

Antimicrobial Resistance & Infection Control, 2021
Abstract Background Carbapenem-resistant Enterobacterales (CRE) is a global threat. Enterobacterales develops carbapenem resistance through several mechanisms, including the production of carbapenemases. We aim to describe the prevalence of Carbapenem-resistant Enterobacterales (CRE) with and without carbapenemase ...
Wantana Paveenkittiporn, Meghan Lyman, Caitlin Biedron, Nora Chea, Charatdao Bunthi, Amy Kolwaite, Noppavan Janejai   +6 more
openaire   +3 more sources

Epidemiology of carbapenem-resistant Enterobacterales infections in Tennessee, 2016-2022. [PDF]

Epidemiol Infect
Abstract This surveillance report describes the epidemiology and clinical outcomes of carbapenem-resistant Enterobacterales (CRE) infections in Tennessee from 2016 to 2022, analysing 570 cases and 406 isolates. The incidence of CRE infections per 100 000 population showed an upward trend.
Muleta D, Nouer SS, Tolley EA, Villegas RM, Taylor J, Harriott MM.   +5 more
europepmc   +4 more sources

An Overview on Phenotypic and Genotypic Characterisation of Carbapenem-Resistant Enterobacterales

Medicina, 2022
Improper use of antimicrobials has resulted in the emergence of antimicrobial resistance (AMR), including multi-drug resistance (MDR) among bacteria. Recently, a sudden increase in Carbapenem-resistant Enterobacterales (CRE) has been observed. This presents a substantial challenge in the treatment of CRE-infected individuals. Bacterial plasmids include
Ali A. Rabaan, Khalid Eljaaly, Saad Alhumaid, Hawra Albayat, Wasl Al-Adsani, Amal A. Sabour, Maha A. Alshiekheid, Jumana M. Al-Jishi, Faryal Khamis, Sara Alwarthan, Mashael Alhajri, Amal H. Alfaraj, Huseyin Tombuloglu, Mohammed Garout, Duaa M. Alabdullah, Elmoeiz Ali Elnagi Mohammed, Fatimah S. Al Yami, Haifa A. Almuhtaresh, Kovy Arteaga Livias, Abbas Al Mutair, Shawqi A. Almushrif, Mai Abdel Haleem A. Abusalah, Naveed Ahmed   +22 more
openaire   +4 more sources